Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00053378 · ClinicalTrials.gov registry record · Phase 2
A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
A Phase 2 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT00053378 is a Phase 2 study that has completed, run by Abbott. The registered enrollment target is 45 participants.
The verdict
NCT00053378, a Phase 2 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients
Interventions
- DRUG paricalcitol injection (Zemplar)
- BEHAVIORAL Effects on calcium regulation
- BEHAVIORAL Administration of elemental Ca during hypocalcemic ICU pts.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2002-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00053378
The ClinicalTrials.gov registry entry for NCT00053378 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which paricalcitol injection (Zemplar) is the first listed.
NCT00053378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00053378 about?
NCT00053378 is a clinical study titled "A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects". A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients
What is the current status of trial NCT00053378?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2002-01.
What interventions are being tested in trial NCT00053378?
The interventions under investigation include: paricalcitol injection (Zemplar) (DRUG), Effects on calcium regulation (BEHAVIORAL), Administration of elemental Ca during hypocalcemic ICU pts. (BEHAVIORAL).
Who is sponsoring clinical trial NCT00053378?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.